Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001094891-26-000053·Lucid Diagnostics Inc.
Schedule 13D ownership disclosure
Lucid Diagnostics Inc
Common Stock, par value $0.001 per share · CUSIP: 54948X109
Event date: 2026-02-03
- Filing-level shares
- 38,816,903.00
- Percent of class
- 27.5%
- PAVmed Inc.Reported CIK 0001624326
Shares: 38,816,903.00 · Class: 27.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001094891-26-000053
- Form type
- SCHEDULE 13D/A
- Filer
- Lucid Diagnostics Inc.
- CIK
- CIK 1799011
- Filed
- Feb 09, 2026
- Reporting period
- Feb 03, 2026
- Description
- Schedule 13D beneficial ownership